跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EVEROLIMUS SWANPOND INVESTMENTS 10 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EVEROLIMUS SWANPOND INVESTMENTS 10 MG COMPRIMIDOS EFG
Approved
STANDARD
EVEROLIMUS SWANPOND INVESTMENTS 10 MG COMPRIMIDOS EFG
Swan Pond Investments Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 10, 2020
Approval ID
1fd59b14023cb7b0
Company
Swan Pond Investments Limited
Type
Standard
Approval Details
Approval Id
1fd59b14023cb7b0
Drug Cima Aemps Name
EVEROLIMUS SWANPOND INVESTMENTS 10 MG COMPRIMIDOS EFG
Register Number
85345
Holder Company Name
Swan Pond Investments Limited
Marketing Company Name
Swan Pond Investments Limited
Authorization Date
2020-08-10
Dosage Form
COMPRIMIDO
Dose
10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Swan Pond Investments Limited
Active Ingredients
EVEROLIMUS
10 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 10, 2020
Approval ID
1fd59b14023cb7b0
Type
Standard
Back to CIMA-AEMPS Approvals
